Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT07013851 |
Title | Clinical Trial to Assess the Efficacy of Dostarlimab as Neoadjuvant Therapy in Patients With MMRd/MSI-H Stage II-III Endometrial Cancer (NADIA) |
Acronym | NADIA |
Recruitment | Not yet recruiting |
Gender | female |
Phase | Phase II |
Variant Requirements | Yes |
Sponsors | Grupo Español de Investigación en Cáncer de Ovario |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | ESP |